Insider Selling: Enfusion, Inc. (NYSE:ENFN) CFO Sells 24,443 Shares of Stock

Enfusion, Inc. (NYSE:ENFN) CFO Bradley Herring sold 24,443 shares of the stock in a transaction dated Friday, December 20th. The shares were sold at an average price of $10.61, for a total transaction of $259,340.23. Following the transaction, the chief financial officer now owns 270,503 shares of the company’s stock, valued at approximately $2,870,036.83. The trade was a 8.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Enfusion Trading Down 5.6 %

ENFN opened at $10.09 on Friday. The company has a 50 day moving average of $9.87 and a 200 day moving average of $9.07. Enfusion, Inc. has a 12 month low of $7.52 and a 12 month high of $11.38. The company has a market cap of $1.30 billion, a PE ratio of 252.31, a price-to-earnings-growth ratio of 3.98 and a beta of 0.97.

Analyst Ratings Changes

ENFN has been the subject of several research analyst reports. Piper Sandler raised their price target on shares of Enfusion from $10.00 to $11.50 and gave the stock a “neutral” rating in a research note on Monday, December 23rd. Stifel Nicolaus boosted their target price on Enfusion from $11.00 to $13.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $10.25.

Hedge Funds Weigh In On Enfusion

Large investors have recently made changes to their positions in the stock. Arizona State Retirement System bought a new stake in shares of Enfusion during the 2nd quarter valued at $86,000. Harbor Capital Advisors Inc. increased its position in shares of Enfusion by 12.4% during the third quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock valued at $113,000 after buying an additional 1,315 shares during the period. Belvedere Trading LLC purchased a new stake in shares of Enfusion in the third quarter worth about $114,000. Paloma Partners Management Co bought a new position in shares of Enfusion in the third quarter valued at approximately $157,000. Finally, The Manufacturers Life Insurance Company grew its stake in Enfusion by 27.7% during the second quarter. The Manufacturers Life Insurance Company now owns 19,562 shares of the company’s stock valued at $167,000 after acquiring an additional 4,239 shares in the last quarter. 81.05% of the stock is owned by institutional investors.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.